4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-21-056466
CIK 0001513525other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:35 PM ET
Size
5.5 KB
Accession
0001213900-21-056466
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2021-11-02+60,000→ 60,000 totalExercise: $3.15From: 2021-11-02Exp: 2031-11-01→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:35 PM ET
- Size
- 5.5 KB